NDSN — Nordson Corporation

The market is bullish after Q3 FY26 blew past expectations: record sales of $818M, up 10.3% y/y, adjusted EPS of $3.25 versus consensus of ~$3.09, a fourth consecutive full-year guidance raise, and a 15% dividend increase. Analysts have been raising targets — DA Davidson to $375 and Oppenheimer to $370 — and the consensus remains a Buy, so the near-term tone is clearly positive.

The trend is clearly accelerating, not just a one-quarter blip. Revenue moved from $669.5M in Q1 FY26 to $740.8M in Q2 and $817.7M in Q3, with y/y growth stepping up to 10.3% in Q3. Operating margin expanded to 27.3% in Q3 versus 25.3% a year earlier, and GAAP EPS rose to $2.73 from $2.21. TTM free cash flow is roughly $728M, up about 34% y/y, and the Q3 order backlog is reported up 35% y/y. This is a cyclical inflection with real margin expansion, not just seasonal noise.

Expensive on trailing numbers: the TTM P/E is 33.3x versus its 5-year average of 28.1x, and P/S of 6.2x is above the 5-year average of 5.2x. But on forward earnings it is less extreme: using FY2026E EPS of roughly $11.89, the forward P/E is about 27.8x, close to the historical average. The PEG of 1.38 is reasonable only if the high near-term growth persists. So: rich versus its own history, but not absurd if the semiconductor upcycle continues.

At $330.84, the stock is pricing in delivery of raised guidance more than a big surprise beyond it. The current price is about 27.8x FY2026E EPS, so if the company merely hits its $11.80-$12.00 guidance, the stock is roughly fairly valued. If Q4 lands strong and FY2027 estimates start moving up, the stock can plausibly work toward the $360+ consensus target. If semiconductor orders slow or backlog growth stalls, the multiple and EPS estimates could compress together — that is the main two-sided risk.

As of 2026-08-27, RSI was 68.04, just below overbought, and the stock was 4.8% above its 20-day SMA, 9.5% above its 50-day SMA, and 19.6% above its 200-day SMA. The trend is firmly up, but the stock is extended after the post-earnings pop. A pullback toward the 20-day area around $316, or the 50-day near $302, would offer a better risk/reward entry without fighting the trend.

• Semiconductor and electronics capex is in an upcycle, driving Advanced Technology Solutions orders and the 35% backlog increase.
• Interest rates still matter for valuation multiples, but Nordson's low leverage — net debt roughly 1.7x EBITDA — means rates are not a meaningful earnings strain.
• Global industrial production is mixed, but Nordson's medical and non-durable consumer end markets add diversification and resilience.
• Bolt-on M&A remains an active growth lever, as shown by the CapstanAG acquisition, though integration risk is always present.
• FX and trade policy are ongoing variables since a meaningful share of revenue comes from outside the U.S.; a strong dollar would pressure reported growth.

• Q4 and full-year FY2026 earnings in mid-December 2026, including initial FY2027 guidance and backlog conversion updates.
• Ex-dividend date on September 10, 2026 for the increased $0.94 quarterly dividend.
• Continued semiconductor packaging/test and inspection order strength, particularly advanced packaging and panel-level applications.
• New product launches such as the ASYMTEK Vantage XL fluid dispensing system for advanced electronics manufacturing.
• Further bolt-on M&A or share repurchase acceleration if free cash flow stays strong.

• Semiconductor cyclicality: ATS is the growth engine right now, and an order pause or inventory correction in chip capex would hit revenue, backlog, and the stock's high multiple at once.
• Valuation reset risk: At 33.3x trailing earnings versus the 5-year average of 28.1x, any guidance miss would likely cause a double-digit drawdown.
• M&A integration risk: Acquisitions like CapstanAG add growth but can underdeliver or strain the balance sheet if leverage rises.
• FX/tariff/geopolitical risk: International exposure leaves results sensitive to currency moves and trade policy changes.
• Customer concentration in electronics/industrial markets, which can create lumpiness despite the diversified segment mix.

Nordson is a high-quality industrial compounder with excellent momentum — record sales, expanding margins, strong free cash flow, a clean balance sheet, and a 63-year dividend growth streak. The problem at $330.84 is that much of that good news is already priced in. As of 2026-08-27, I see a good company but a neutral entry point; the risk/reward gets more interesting on a meaningful pullback or if FY2027 estimates begin to move up sharply.

I applied a 29.5x multiple to FY2026E EPS of $11.90 (guidance midpoint and close to the consensus estimate), a modest premium to Nordson's 5-year average P/E of 28.1x justified by accelerating organic growth, margin expansion, 35% backlog growth, and reduced leverage. That works out to approximately $351, which is between the current price and the analyst consensus target.